Cardiac Amyloidosis with Asymmetrical Septal Hypertrophy and Deterioration After Nifedipine
Overview
Authors
Affiliations
Emerging from the Darkness. Sudden Cardiac Death in Cardiac Amyloidosis.
Cammalleri V, de Luca V, Antonelli G, Annibali O, Nusca A, Mega S Rev Cardiovasc Med. 2024; 23(10):345.
PMID: 39077150 PMC: 11267335. DOI: 10.31083/j.rcm2310345.
Laptseva N, Rossi V, Sudano I, Schwotzer R, Ruschitzka F, Flammer A J Clin Med. 2023; 12(7).
PMID: 37048664 PMC: 10095126. DOI: 10.3390/jcm12072581.
Two Decades of Cardiac Amyloidosis: A Danish Nationwide Study.
Westin O, Butt J, Gustafsson F, Schou M, Salomo M, Kober L JACC CardioOncol. 2021; 3(4):522-533.
PMID: 34729524 PMC: 8543084. DOI: 10.1016/j.jaccao.2021.05.004.
Electrophysiological Manifestations of Cardiac Amyloidosis: State-of-the-Art Review.
Hartnett J, Jaber W, Maurer M, Sperry B, Hanna M, Collier P JACC CardioOncol. 2021; 3(4):506-515.
PMID: 34729522 PMC: 8543134. DOI: 10.1016/j.jaccao.2021.07.010.
Clinical management of amyloid cardiomyopathy.
Kim M, Kolseth C, Carlson D, Masri A Heart Fail Rev. 2021; 27(5):1549-1557.
PMID: 34471997 DOI: 10.1007/s10741-021-10159-w.